Loading...
Geron Corp (GERN) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock shows some positive signals, such as hedge fund buying and a bullish moving average trend, the lack of recent news, weak financial performance, and reduced analyst price targets suggest a cautious approach. The technical indicators and options data do not strongly support immediate entry, and the stock's near-term growth potential appears limited.
The technical indicators show a bullish moving average trend (SMA_5 > SMA_20 > SMA_200), with the MACD histogram above 0 and positively contracting. However, the RSI is in the neutral zone, and the stock is trading close to its resistance level (R1: 1.656). The stock has a 60% chance to increase by 0.71% in the next week and 4.15% in the next month.

Hedge funds have significantly increased their buying activity (up 226.92% over the last quarter). The stock has a bullish moving average trend and a potential for modest growth in the next month.
There is no recent news or significant insider activity to support a strong positive sentiment.
In Q3 2025, revenue increased by 67.05% YoY to $47.23M. However, net income dropped by 30.32% YoY to -$18.43M, EPS fell by 25% YoY to -0.03, and gross margin slightly declined to 97.79%.
Analyst Tara Bancroft from TD Cowen maintains a Buy rating but has lowered the price target from $4 to $3 ahead of Q4 results, reflecting cautious optimism.